Faron Pharmaceuticals Oy

FARN.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-£26-£31-£29-£21
Dep. & Amort.£0£0£0£0
Deferred Tax£0£0£0£0
Stock-Based Comp.£1£2£1£1
Change in WC-£5£3£5-£2
Other Non-Cash£7£1-£1-£1
Operating Cash Flow-£23-£24-£23-£22
Investing Activities
PP&E Inv.-£0-£0-£0-£0
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.-£0£0£0£0
Investing Cash Flow-£0-£0-£0-£0
Financing Activities
Debt Repay.-£0-£1£10£1
Stock Issued£32£26£13£26
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.-£6-£1-£0-£1
Financing Cash Flow£26£24£23£26
Forex Effect£0-£0£0-£0
Net Chg. in Cash£3-£0£0£3
Supplemental Information
Beg. Cash£7£7£7£4
End Cash£10£7£7£7
Free Cash Flow-£23-£24-£23-£23
Faron Pharmaceuticals Oy (FARN.L) Financial Statements & Key Stats | AlphaPilot